These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 8801435)

  • 21. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1999 Jun; 93(4):325-9. PubMed ID: 10656034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational use of drugs against Plasmodium falciparum.
    Warhurst DC; Duraisingh MT
    Trans R Soc Trop Med Hyg; 2001; 95(4):345-6. PubMed ID: 11579870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs. Reinventing an ancient cure for malaria.
    Marshall E
    Science; 2000 Oct; 290(5491):437-9. PubMed ID: 11183758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
    Rudrapal M; Chetia D
    Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antimalarials. A risk-benefit analysis.
    Nosten F; Price RN
    Drug Saf; 1995 Apr; 12(4):264-73. PubMed ID: 7646825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
    Li Y; Wu YL
    Med Trop (Mars); 1998; 58(3 Suppl):9-12. PubMed ID: 10212890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in the research of artemisinin and its analogues as antimalarials: an update.
    Sriram D; Rao VS; Chandrasekhara KV; Yogeeswari P
    Nat Prod Res; 2004 Dec; 18(6):503-27. PubMed ID: 15595609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.
    Hien TT
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S7-8. PubMed ID: 8053033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides.
    Posner GH; O'Neill PM
    Acc Chem Res; 2004 Jun; 37(6):397-404. PubMed ID: 15196049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives.
    Le TA; Davis TM; Tran QB; Nguyen VP; Trinh KA
    Clin Infect Dis; 1997 Oct; 25(4):923-5. PubMed ID: 9356813
    [No Abstract]   [Full Text] [Related]  

  • 33. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial Effect of 3-Methoxy-1,2-Dioxetanes on the Erythrocytic Cycle of Plasmodium falciparum.
    Lopes NS; Yoshitake AM; Silva AF; Oliveira VX; Silva LS; Pinheiro AA; Ciscato LF
    Chem Biol Drug Des; 2015 Dec; 86(6):1373-7. PubMed ID: 26032859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogues that block the network.
    Akompong T; VanWye J; Ghori N; Haldar K
    Mol Biochem Parasitol; 1999 Jun; 101(1-2):71-9. PubMed ID: 10413044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artemisinin derivatives for treating uncomplicated malaria.
    McIntosh HM; Olliaro P
    Cochrane Database Syst Rev; 2000; 1999(2):CD000256. PubMed ID: 10796519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Qinghaosu and its derivatives].
    Barabe P; Touze JE; Jeandel P
    Med Trop (Mars); 1982; 42(4):433-6. PubMed ID: 6815404
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
    Noedl H; Wernsdorfer WH; Krudsood S; Wilairatana P; Viriyavejakul P; Kollaritsch H; Wiedermann G; Looareesuwan S
    Am J Trop Med Hyg; 2001 Dec; 65(6):696-9. PubMed ID: 11791959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artemisinin and its derivatives: an important new class of antimalarial agents.
    Balint GA
    Pharmacol Ther; 2001; 90(2-3):261-5. PubMed ID: 11578659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin resistance: how can we find it?
    Noedl H
    Trends Parasitol; 2005 Sep; 21(9):404-5. PubMed ID: 16046187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.